PRCT
PROCEPT BioRobotics Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -1.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | +5 | 33.21M | $750.18M | +11 | −6 |
| Q1 2026 | 91 | -1 | 33.28M | $833.46M | +12 | −14 |
| Q4 2025 | 93 | +1 | 39.36M | $1.24B | +3 | −1 |
| Q3 2025 | 16 | -3 | 25.33M | $904.19M | — | −3 |
| Q2 2025 | 16 | 0 | 23.48M | $1.35B | +1 | −1 |
| Q1 2025 | 13 | +2 | 6.67M | $388.41M | +2 | — |
| Q4 2024 | 11 | 0 | 6.19M | $498.09M | +1 | −1 |
| Q3 2024 | 10 | -1 | 3.73M | $299.03M | — | −1 |
| Q2 2024 | 11 | — | 4.04M | $246.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 7.80M | — | $449.26M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | The Vanguard Group ✦ (passive) | 5.25M | — | $302.29M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passive) | 4.21M | — | $242.39M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 4 | T. Rowe Price ✦ | 1.32M | +25.3% | $76.17M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (passive) | 1.30M | +9.7% | $74.83M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passive) | 1.27M | +6.9% | $73.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 876.36K | +179.2% | $50.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 8 | Wellington Management ✦ | 615.20K | -36.1% | $35.44M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 9 | Two Sigma Investments ✦ | 348.15K | -27.6% | $20.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 190.29K | -65.0% | $10.96M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 100.00K | +100.0% | $5.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 73.66K | -82.8% | $4.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 64.15K | New | $3.70M | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 53.45K | +182.9% | $3.08M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 15 | Citadel Advisors ✦ | 7.99K | -38.3% | $459,994 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 4.15K | -96.4% | $238,867 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $3.70M | 0.0% |
Exited
| Renaissance Technologies | $18.32M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 254 holders, 55.53M shares, $1.28B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · President, CEO · 23.90K sh @ 20.85 · $498,315
Open-market sales (S)
Officer · 373 sh · $7,815
Officer · 297 sh · $6,223
Officer · 373 sh · $7,815
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology